Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on the development and commercialization of therapies for people living with rare diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomer... Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on the development and commercialization of therapies for people living with rare diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN) - rare kidney disorders that often lead to end-stage kidney disease. 더 보기
기간 | 변동 | 변동 % | 시가 | 고가 | 저가 | 평균 일일 거래량 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.51 | -2.43320610687 | 20.96 | 21.56 | 19.765 | 1114151 | 20.55097484 | CS |
4 | 2.8 | 15.8640226629 | 17.65 | 21.56 | 16.8 | 1237931 | 19.06894711 | CS |
12 | 3.19 | 18.4820393975 | 17.26 | 21.56 | 16.588 | 1277355 | 18.46711159 | CS |
26 | 10.25 | 100.490196078 | 10.2 | 21.56 | 7.931 | 1538133 | 15.56805691 | CS |
52 | 11.26 | 122.524483134 | 9.19 | 21.56 | 5.12 | 1355737 | 12.13651742 | CS |
156 | -5.64 | -21.6174779609 | 26.09 | 30.35 | 5.12 | 1223258 | 15.29943524 | CS |
260 | -4.7 | -18.6878727634 | 25.15 | 33.0899 | 5.12 | 1086733 | 16.65804615 | CS |
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관